BRCA1 and pachyonychia congenita: An increased risk of PC has been found in Ashkenazi Jews in whom more than 2% carry germline mutations in BRCA1 or BRCA2 and in PC with intraductal histology that appear to have greater genomic instability compared to those with adenocarcinoma histology (35–38).